PRECIPIO INC (PRPO) Stock Price, Forecast & Analysis
USA - NASDAQ:PRPO - US74019L6020 - Common Stock
PRPO Key Statistics, Chart & Performance
The current stock price of PRPO is 20 USD. In the past month the price increased by 5.05%. In the past year, price increased by 227.86%.
PRPO Latest News, Press Relases and Analysis
PRPO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.53 | 100.19B | ||
| CI | THE CIGNA GROUP | 9.31 | 70.62B | ||
| LH | LABCORP HOLDINGS INC | 15.97 | 21.00B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.39 | 20.07B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 110.32 | 19.93B | ||
| GH | GUARDANT HEALTH INC | N/A | 12.06B | ||
| HIMS | HIMS & HERS HEALTH INC | 75.98 | 9.27B | ||
| DVA | DAVITA INC | 13.4 | 8.84B | ||
| CHE | CHEMED CORP | 19.76 | 6.33B | ||
| RDNT | RADNET INC | 217.53 | 6.02B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 32.49 | 5.87B | ||
| OPCH | OPTION CARE HEALTH INC | 18.56 | 4.49B |
Related stock screener links
About PRPO
Company Profile
Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. The company is headquartered in New Haven, Connecticut and currently employs 54 full-time employees. The company went IPO on 2000-07-18. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.
Company Info
PRECIPIO INC
4 Science Park
New Haven CONNECTICUT 06511 US
CEO: Ilan Danieli
Employees: 54
Phone: 12037877888
PRECIPIO INC / PRPO FAQ
What does PRPO do?
Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. The company is headquartered in New Haven, Connecticut and currently employs 54 full-time employees. The company went IPO on 2000-07-18. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.
What is the stock price of PRECIPIO INC today?
The current stock price of PRPO is 20 USD. The price decreased by -1.4% in the last trading session.
Does PRECIPIO INC pay dividends?
PRPO does not pay a dividend.
How is the ChartMill rating for PRECIPIO INC?
PRPO has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
On which exchange is PRPO stock listed?
PRPO stock is listed on the Nasdaq exchange.
What sector and industry does PRECIPIO INC belong to?
PRECIPIO INC (PRPO) operates in the Health Care sector and the Health Care Providers & Services industry.
Can you provide the PE ratio for PRPO stock?
PRECIPIO INC (PRPO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.21).
PRPO Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to PRPO. When comparing the yearly performance of all stocks, PRPO is one of the better performing stocks in the market, outperforming 97.89% of all stocks.
PRPO Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to PRPO. PRPO has a bad profitability rating. Also its financial health evaluation is rather negative.
PRPO Financial Highlights
Over the last trailing twelve months PRPO reported a non-GAAP Earnings per Share(EPS) of -1.21. The EPS increased by 54.83% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -9.57% | ||
| ROE | -14.66% | ||
| Debt/Equity | 0.05 |